NAFDAC Warns On Cough Syrup From Gambia

Advertisement

The National Agency for Food and Drugs Administration and Control (NAFDAC) has notified Healthcare providers and the public of the death of 66 children in Gambia following the use of four substandard cough syrups as reported by WHO in September 2022.

The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

Laboratory analysis of samples of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.

 

Diethylene glycol and ethylene glycol are toxic to humans when consumed and can prove fatal.

Toxic effects can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.

The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India). To date, the stated manufacturer.

Advertisement

Leave a Reply

Your email address will not be published. Required fields are marked *